Human prostacyclin synthase gene and hypertension: The Suita Study

Circulation

Volumn 100, Issue 22, 1999, Pages 2231-2236

  Iwai, Naoharu ^a   Katsuya, Tomohiro ^b   Ishikawa, Kazuhiko ^b   Toshifumi, Mannami ^a   Ogata, Jun ^a   Higaki, Jitsuo ^b   Ogihara, Toshio ^b   Tanabe, Tadashi ^a   Baba, Shunroku ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Blood pressure; Genetics; Hypertension; Prostaglandins

Indexed keywords

DNA; PROSTACYCLIN SYNTHASE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 0032749227     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.22.2231     Document Type: Article

References (21)

1. Moncada S, Vane JR. Arachidonic acid metabolites and the interaction between platelets and blood-vessel walls. N Engl J Med. 1979;300:1142-1147.
2. Pomerantz KB, Hajjar DP. Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism. Arteriosclerosis. 1989;9:413-429.
3. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev. 1987;30:293-331.
4. Vane JR, Botting RM. Pharmacodynamic profile of prostacyclin. Am J Cardiol. 1995;75:3A-10A.
5. Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita Study. Stroke. 1997;28:518-525.
6. Yokoyama C, Yabuki T, Inoue H, Tone Y, Hara S, Hatae T, Nagata M, Takahashi E, Tanabe T. Human gene encoding prostacyclin synthase: genomic organization, chromosomal localization, and promoter activity. Genomics. 1996;36:296-304.
7. Iwai N, Matsunaga M, Kita T, Tei M, Kawai C. Regulation of angiotensin converting enzyme activity in cultured human vascular endothelial cells. Biochem Biophys Res Commun. 1987;149:1179-1185.
8. Glagov S, Vito R, Giddens DP, Zarins CK. Micro-architecture and composition of artery wall: relationship to location, diameter and the distribution of mechanical stress. J Hypertens. 1992;10(suppl 6):s101-s104.
9. Benetos A, Laurent S, Asmar RG, Lacolley P. Large artery stiffness in hypertension. J Hypertens. 1997;15(suppl 2):s89-s97.
10. Miyata A, Hara S, Yokoyama C, Inoue H, Ullrich V, Tanabe T. Molecular cloning and expression of human prostacyclin synthase. Biochem Biophys Res Commun. 1994;200:1728-1734.
11. Tone Y, Inoue H, Yokoyama C, Hatae T, Oida H, Narumiya S, Shigemoto R, Yukawa S, Tanabe T. The regional distribution and cellular localization of mRNA encoding rat prostacyclin synthase. Eur J Cell Biol. 1997;72:268-277.
12. Hara S, Miyata A, Yokoyama C, Inoue H, Brugger R, Lottspeich F, Ullrich V, Tanabe T. Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells. J Biol Chem. 1994;269:19897-19903.
13. Bruggeman LA, Pellicoro JA, Horigan EA, Klotman PE. Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression. Kidney Int. 1993;43:1219-1225.
14. Yu H, Gallagher AM, Garfin PM, Printz MP. Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression. Hypertension. 1997;30:1047-1053.
15. Franklin SS, Gustin W IV, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation. 1997;96:308-315.
16. Darne B, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension. 1989;13:392-400.
17. Mitchell GF, Moye LA, Braunwald E, Rouleau J-L, Bernstein V, Geltman EM, Flaker GC, Pfeffer M, for the SAVE Investigators. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. Circulation. 1997;96:4254-4260.
18. Fitzgerald DJ, Entman SS, Mulloy K, Fitzgerald GA. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation. 1987;75:956-963.
19. Fitzgerald GA, Smith B, Pederson AK, Brash AR. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med. 1984;310:1065-1068.
20. Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, Ichikawa A, Aze Y, Tanaka T, Yoshida N, Ueno A, Oh-ishi S, Narumiya S. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature. 1997;388:678-682.
21. Krushkal J, Ferrell R, Mockrin C, Turner ST, Sing CF, Boerwinkle E. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation. 1999;99:1407-1410.